Perceptive Pharma Research | Richmond, TX
Status and phase
Conditions
Treatments
About
This phase 2 trial will evaluate the effects of EP547 in subjects with cholestatic pruritus due to Primary Biliary Cholangitis (PBC) or Primary Sclerosing Cholangitis (PSC)
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
58 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Escient Clinical Trials
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal